Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity.
Cancer Commun (Lond)
; 43(10): 1178-1182, 2023 Oct.
Article
de En
| MEDLINE
| ID: mdl-37525513
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
Cancer Commun (Lond)
Année:
2023
Type de document:
Article